These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36084198)

  • 1. Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test.
    Lechiile K; Leeme TB; Tenforde MW; Bapabi M; Magwenzi J; Maithamako O; Mulenga F; Mohammed T; Ngidi J; Mokomane M; Lawrence DS; Mine M; Jarvis JN
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):502-507. PubMed ID: 36084198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    Gils T; Kamele M; Madonsela T; Bosman S; Ngubane T; Joseph P; Reither K; Bresser M; Vlieghe E; Decroo T; Ayakaka I; Lynen L; Van Heerden A
    PLoS One; 2023; 18(12):e0296197. PubMed ID: 38134020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settings.
    Vidhyavathi V; Iqbal HS; Kanthamani K; Solomon SS; Nandagopal P; Luchters S; Pham MD; Forbes J; Crowe SM; McMurran C; Anderson DA; Balakrishnan P
    J Int Med Res; 2020 Sep; 48(9):300060520955028. PubMed ID: 32985310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening.
    Ndlovu Z; Massaquoi L; Bangwen NE; Batumba JN; Bora RU; Mbuaya J; Nzadi R; Ntabugi N; Kisaka P; Manciya G; Moudashirou R; Pangani H; Mangochi P; Makoko R; Van Laeken D; Kwitonda C; Ronoh Y; Kuwenyi K; Ortuno R; Mangwanya D; Zvidzai E; Mupepe T; Zinyowera S; Fajardo E; Ellman T
    PLoS One; 2020; 15(4):e0230453. PubMed ID: 32243435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.
    Luchters S; Technau K; Mohamed Y; Chersich MF; Agius PA; Pham MD; Garcia ML; Forbes J; Shepherd A; Coovadia A; Crowe SM; Anderson DA
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT CD4 Advanced Disease test in seven countries.
    Gils T; Hella J; Jacobs BKM; Sossen B; Mukoka M; Muyoyeta M; Nakabugo E; Van Nguyen H; Ubolyam S; Macé A; Vermeulen M; Nyangu S; Sanjase N; Sasamalo M; Dinh HT; Ngo TA; Manosuthi W; Jirajariyavej S; Denkinger CM; Nguyen NV; Avihingsanon A; Nakiyingi L; Székely R; Kerkhoff AD; MacPherson P; Meintjes G; Reither K; Ruhwald M
    J Infect Dis; 2024 Jul; ():. PubMed ID: 39046150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A profile of the Visitect® CD4 and Visitect® CD4 advanced disease for management of people living with HIV.
    Pham MD; Stoove M; Crowe S; Luchters S; Anderson D
    Expert Rev Mol Diagn; 2022 Mar; 22(3):247-252. PubMed ID: 35226590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of the Visitect Advanced Disease point-of-care CD4 platform: a pragmatic mixed-methods multisite validation, costing, and qualitative analysis.
    Nalintya E; Sekar P; Namakula OL; Tadeo KK; Kwizera R; Apeduno L; Naluyima DR; Nanano R; Mujungu L; Lehman A; Adzemovic T; Amperiize M; Kavuma P; Kasone V; Fieberg A; Nerima P; Dai B; Meya DB; Boulware DR; Rajasingham R
    J Acquir Immune Defic Syndr; 2024 Aug; ():. PubMed ID: 39159398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced HIV disease: A review of diagnostic and prophylactic strategies.
    Lehman A; Ellis J; Nalintya E; Bahr NC; Loyse A; Rajasingham R
    HIV Med; 2023 Aug; 24(8):859-876. PubMed ID: 37041113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test.
    Scorgie F; Mohamed Y; Anderson D; Crowe SM; Luchters S; Chersich MF
    BMC Health Serv Res; 2019 Feb; 19(1):123. PubMed ID: 30764808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid CD4 cell count determination and
    Andreani M; Frola CE; Cáceres DH; Bozzano C; Diaz L; Cattani ME; Rodriguez-Tudela JL; Rolón MJ; Guelfand L
    IJID Reg; 2024 Sep; 12():100403. PubMed ID: 39188885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
    Leeme TB; Mine M; Lechiile K; Mulenga F; Mosepele M; Mphoyakgosi T; Muthoga C; Ngidi J; Nkomo B; Ramaabya D; Tau M; Tenforde MW; Hayes R; Jarvis JN
    HIV Med; 2021 Jan; 22(1):1-10. PubMed ID: 32876378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near patient CD4 count in a hospitalized HIV patient population.
    Givens M; Weaver A; Bickman S; Logan C; Noormahomed EV; Patel S; Schooley RT; Benson CA; Lochhead MJ
    Cytometry B Clin Cytom; 2017 Nov; 92(6):451-455. PubMed ID: 25917935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol.
    Gils T; Lynen L; Muhairwe J; Mashaete K; Lejone TI; Joseph P; Ngubane T; Keter AK; Reither K; van Heerden A
    BMJ Open; 2022 Feb; 12(2):e057291. PubMed ID: 35131835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of point-of-care HIV and CD4 field testing by lay healthcare workers in the Botswana Combination Prevention Project.
    Bile EC; Bachanas PJ; Jarvis JN; Maurice F; Makovore V; Chebani L; Jackson KG; Birhanu S; Maphorisa C; Mbulawa MB; Alwano MG; Sexton C; Modise SK; Bapati W; Segolodi T; Moore J; Fonjungo PN
    J Virol Methods; 2023 Jan; 311():114647. PubMed ID: 36343742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field evaluation of the performance and testing costs of a rapid point-of-care test for syphilis in a red-light district of Manaus, Brazil.
    Benzaken AS; Sabidó M; Galban EG; Pedroza V; Vasquez F; Araújo A; Peeling RW; Mayaud P
    Sex Transm Infect; 2008 Aug; 84(4):297-302. PubMed ID: 18305119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana.
    Moran Z; Sacks JA; Frimpong FK; Frimpong AB; Ben Amor Y
    PLoS One; 2019; 14(2):e0212684. PubMed ID: 30794637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.